Zobrazeno 1 - 10
of 141
pro vyhledávání: '"L-M Ching"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
K Guo, L-M Ching, L-C S Wang, Kimiora Henare, Sofian M. Tijono, Brian D. Palmer, Steven M. Albelda
Publikováno v:
British Journal of Cancer
Background: Species selectivity of DMXAA (5,6-dimethylxanthenone-4-acetic acid, Vadimezan) for murine cells over human cells could explain in part the recent disappointing phase III trials clinical results when preclinical studies were so promising.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0e9ef5de0dc57de60f673961cb2e73
https://doi.org/10.1038/bjc.2013.101
https://doi.org/10.1038/bjc.2013.101
Publikováno v:
Cancer Genetics and Cytogenetics. 118:24-27
We describe a case of T-lymphoblastic lymphoma (T-LBL) in a 13-year-old boy in which conventional cytogenetic analysis of lymph node tissue showed complex karyotypic aberrations including add(1p), add(2q), and multiple chromosomal deletions involving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8510a5bcf1e72ea6b686a8f17a663974
https://doi.org/10.1016/s0165-4608(99)00174-0
https://doi.org/10.1016/s0165-4608(99)00174-0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Genetics and Cytogenetics. 93:172-176
Three consecutive cases of pediatric myelodysplastic syndrome (MDS) diagnosed over a three-year period in Queen Mary Hospital, Hong Kong, were described. Depending on the classification system used, they comprised two cases of chronic myelomonocytic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::120374ba633858e8cda95fc52ccffdf5
https://doi.org/10.1016/s0165-4608(96)00202-6
https://doi.org/10.1016/s0165-4608(96)00202-6
Autor:
Tong Zhang, Long Jun Gu, Shao Qin Kuang, Wei Huang, Sai Juan Chen, Zhu Chen, Shuo Dong, L. M. Ching, Qiu Hua Huang, L. C. Chang
Publikováno v:
Cancer Genetics and Cytogenetics. 81:76-82
The TAL-1 gene is located on chromosome 1p32. In about 20% of T-cell acute lymphoblastic leukemias (T-ALL), this gene is disrupted in its 5' portion by a site-specific 100-kg deletion and is fused with the 5' part of the SIL gene, to form SIL-TAL-1 c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5a26ab661819f1ec0ea6cfebc865784
https://doi.org/10.1016/s0165-4608(94)00209-6
https://doi.org/10.1016/s0165-4608(94)00209-6
Publikováno v:
The Journal of Immunology. 153:4684-4693
The synthetic flavone analogue 5,6-dimethylxanthenone-4-acetic acid (5,6-MeXAA) has shown promise as an antitumor agent and is currently a candidate for clinical trials. Because 5,6-MeXAA has been shown in a murine macrophage and a human myelomonocyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85095af329bf2f1974a09e67d9fa14ad
https://doi.org/10.4049/jimmunol.153.10.4684
https://doi.org/10.4049/jimmunol.153.10.4684
Publikováno v:
American Journal of Hematology. 43:211-215
The translocation (8;21)(q22;q22) is commonly associated with acute myeloid leukemia (AML) M2 according to the French-American-British (FAB) classification. We describe 11 cases of t(8;21) diagnosed by strict FAB criteria. Six cases were diagnosed as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c89f43556b26769bbb91de591ec8489a
https://doi.org/10.1002/ajh.2830430310
https://doi.org/10.1002/ajh.2830430310
Publikováno v:
Cancer Genetics and Cytogenetics. 62:154-159
The karyotypes of 98 patients between the ages of 8 and 81 years with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and chronic myeloid leukemia (CML) are presented. Although the well-described cyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c59db7b7b711b8b7a84c66cd80cbc96f
https://doi.org/10.1016/0165-4608(92)90255-7
https://doi.org/10.1016/0165-4608(92)90255-7
Publikováno v:
Cancer research. 61(5)
The promise of cancer immunotherapy is that it will not only eradicate primary tumors but will generate systemic antitumor immunity capable of destroying distant metastases. A major problem that must first be surmounted relates to the immune resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f74a94dbb347212696ea18e12e2fd54
https://pubmed.ncbi.nlm.nih.gov/11280751
https://pubmed.ncbi.nlm.nih.gov/11280751